Clinical Trial Update: Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating the metabolic and behavioral effects of Contrave (naltrexone/bupropion) as potential mechanisms of weight loss in adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CONTRAVE (bupropion/naltrexone)

Snippet

Sponsor: The Royal's Institute of Mental Health Research | Conditions: Obesity, Weight Loss | Phase 4 | Status: RECRUITING